Gates Capital Management Increases Exposure to Richardson Electronics, Ltd. (RELL)

Gates Capital Management, a fund managed by Jeffrey Gates, has disclosed, in a newly amended filing with the Securities and Exchange Commission, incresing its position in Richardson Electronics, Ltd. (NASDAQ:RELL). The fund currently holds around 2.7 million shares of the company, versus some 2.6 million held at the end of September, as disclosed in the latest 13F. The holding amasses 22.73% of the company’s common stock. The stake is activist by nature and has a value of over $30.2 million, at the current stock price of Richardson Electronics.

Richardson Electronics Ltd. (RELL)

Richardson Electronics, Ltd. (NASDAQ:RELL)’s stock edged up by around 1% since the beginning of the year. For the first quarter of its fiscal 2014, ended August 31, the company posted an annual 3.9% decline in net sales, which totaled $34.3 million. The gross margin remained almost flat over the year at 29.8%. The company posted a net income of $2.0 million, which represent $0.14 per share, which represents a boost from $0.6 million, or $0.04 per share in the same period of last year.

Earlier in September, Gates reported upping its position in Richardson Electronics, Ltd. (NASDAQ:RELL) to close to 2.6 million shares, from 2.5 million held earlier. At the same time, the fund changed the nature of the stake to activist. In addition to Gates, Rgm Capital, managed by Robert G. Moses disclosed holding a $13.4 million stake in the company, which amasses 1.2 million shares. Chuck Royce’s Royce & Associates also reported holding some 916,400 shares of Richardson Electronics, Ltd. (NASDAQ:RELL), worth $10.4 million.

A couple of days ago, Gates disclosed, in another filing, increasing its position in Darling International Inc. (NYSE:DAR) to 6.0 million shares, from 4.9 million. Currently the fund holds 5.1% of the company’s common stock. Earlier, Gates almost doubled its position in Headwaters Inc (NYSE:HW) to 7.37 million shares, equal to 10.1% of the company’s common stock.

Disclosure: none

Recommended Reading:

Sandell Asset Management Picks Up Its Stake in Bob Evans Farms Inc (BOBE)

Charles Davidson, Wexford Capital Keep Selling Diamondback Energy Inc (FANG) Shares

Clifton S. Robbins, Blue Harbour Group Up Their Stake in CACI International Inc (CACI)

 

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!